SUMMARY OF THE CONNECTION BETWEEN DIABETES MELLITUS TYPE 2  AND NON-ALCOHOLIC FATTY LIVER DISEASE

Khamidva M.I.

Authors

Khamidva M.I. Department of Gospital therapy and Endocrinology Assistant Andijan State Medical Institute.

Keywords:

Non-alcoholic fatty liver disease, metabolic syndrome, liver inflammation, diabetes mellitus

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in Western countries and is expected to become the most common indication for liver transplantation by 2030. Over the past decade, it has been shown that the clinical significance of NAFLD is not limited to increased morbidity and mortality associated with liver disease. More and more studies indicate that NAFLD is multisystemic, affecting other organs as a result of multiple pathological pathways. In particular, NAFLD increases the risk of developing type 2 diabetes mellitus (DM), cardiovascular diseases, and chronic kidney disease [1].

References

Byrne CD NAFLD: A multisystem disease. J. Hepatol., 2016, Vol. 62, No. 1, pp. 47–64.

2. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol., 2016, Vol. 64, No. 6, pp. 1388–1402, doi:10.1016/j.jhep.2015.11.004.

Targher G, Marchesini G, Byrne CD. Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon? Diabetes Metab. 2016 Jun;42(3):142-56. doi: 10.1016/j.diabet.2016.04.002. Epub 2016 Apr 30. PMID: 27142870.

Lonardo A, Ballestri S, Guaraldi G, Nascimbeni F, Romagnoli D, Zona S, Targher G. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV. World J Gastroenterol. 2016 Nov 28;22(44):9674-9693. doi: 10.3748/wjg.v22.i44.9674. PMID: 27956792; PMCID: PMC5124973.

Lonardo A, Ballestri S, Marchesini G, Angulo P, Loria P. Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. Dig Liver Dis. 2015 Mar;47(3):181-90. doi: 10.1016/j.dld.2014.09.020. Epub 2014 Nov 18. PMID: 25739820.

Ekstedt M, Franzén LE, Holmqvist M. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease. Scand J Gastroenterol. 2009;44(3):366-374. doi: 10.1080/00365520802555991

Doycheva I, Cui J, Nquyen P, et al. Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE. Aliment Pharmacol Ther. 2016;43(1):83-95. doi: 10.1111/apt.13405

Sun W, Zhang D, Sun J, et al. Association between non-alcoholic fatty liver disease and autonomic dysfunction in a Chinese population. QJM 2015;108(8):617-624.